ObsEva SA
OBSN | SW
Overview
Corporate Details
- ISIN(s):
- CH1260041939
- LEI:
- 549300PNZ0UEJVKN1618
- Country:
- Switzerland
- Address:
- CHEMIN DES AULX 12, 1228 PLAN-LES-OUATES
- Website:
- https://www.obseva.com/
- Sector:
- Health Care
- Industry:
- Pharmaceuticals
Description
Founded in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy. We believe our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-17 | N/A | Non-Executive member | Buy | None | 2,058.00 CHF |
| 2022-03-16 | N/A | Non-Executive member | Buy | None | 27,010.00 CHF |
| 2022-03-15 | N/A | Non-Executive member | Buy | None | 23,642.00 CHF |
| 2022-02-08 | N/A | Non-Executive member | Buy | None | 64,161.00 CHF |
| 2022-02-01 | N/A | Non-Executive member | Buy | None | 70,716.00 CHF |
| 2022-01-24 | N/A | Non-Executive member | Buy | None | 69,748.00 CHF |
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 183,535.00 CHF |
| 2022-01-10 | N/A | Non-Executive member | Buy | None | 177,643.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Halychpharm | Ukraine | GFARM | |
|
Hamlet BioPharma AB | Sweden | HAMLET | |
|
Harm Reduction Group AB | Sweden | NOHARM | |
|
Heidelberg Pharma AG | Germany | HPHA | |
|
HELLENIC DYNAMICS PLC | United Kingdom | HELD | |
|
HIKMA Pharmaceuticals PLC | United Kingdom | HIK | |
|
H. Lundbeck A | Denmark | HLUN | |
|
Hod-Assaf Industries Ltd. | Israel | HOD | |
|
HUDDLED GROUP PLC | United Kingdom | HUD | |
|
Iconovo AB | Sweden | ICO |